NexImmune Appoints Sol Barer as Chairman of the Board of Directors

NEXT STORY
Salarius Pharmaceuticals Receives FDA Fast Track Designation for Lead Drug Candidate, Seclidemstat, in Relapsed or Refractory Ewing Sarcoma
PREV STORY
BeiGene Announces Results of Phase 3 ASPEN Trial of Zanubrutinib Compared to Ibrutinib for the Treatment of Patients with Waldenström’s Macroglobulinemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE

Strong financial performance in H1 2018 Three medium-term strategic growth drivers fully on track ...

author_avatar
NASDAQ Market News

AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...

author_avatar
NASDAQ Market News

New Imaging Suite at NYC Health + Hospitals/Coney Island Presents a Bright Picture of Enhanced Patient Care

Brooklyn, New York, Aug. 23, 2018 (GLOBE NEWSWIRE) -- (Brooklyn, NY – August 22, ...

author_avatar
NASDAQ Market News